V

Verona Pharma plc
D

VRNA

38.790
USD
0.90
(2.38%)
Market Closed
Volume
22,975
EPS
-2
Div Yield
-
P/E
-19
Market Cap
3,174,231,084
OverviewSignalsIdeasNews
Related Instruments
    A
    ALT
    -0.85500
    (-10.11%)
    7.60000 USD
    B
    BNTX
    -3.740
    (-3.61%)
    99.740 USD
    MRNA
    MRNA
    -2.950
    (-7.42%)
    36.830 USD
    N
    NVAX
    0.12000
    (1.67%)
    7.32500 USD
    V
    VXRT
    -0.05030
    (-7.97%)
    0.58050 USD
    More
News

Title: Verona Pharma plc

Sector: Healthcare
Industry: Biotechnology
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.